Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:AbbVie
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:focusesOn |
developing therapeutics targeting innate immune pathways
|
| gptkbp:foundedIn |
2016
|
| gptkbp:headquartersLocation |
gptkb:Seattle,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mavupharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:website |
https://www.mavupharma.com/
|
| gptkbp:bfsParent |
gptkb:Frazier_Healthcare_Ventures
|
| gptkbp:bfsLayer |
7
|